SCHEMBL18858293

SCHEMBL18858293

c1cc(-c2cc3ccccc3cn2)cc(-c2ccnc3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.51
▸ ACVR1 Q04771 4/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ AURKA O14965 1/20 0.44
▸ TTK P33981 1/20 0.44
▸ AURKB Q96GD4 1/20 0.44
▸ INCENP Q9NQS7 1/20 0.44
▸ TGFBR1 P36897 4/20 0.44
▸ MAPK14 Q16539 4/20 0.44
▸ GRM4 Q14833 3/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ MTNR1A P48039 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ IDO1 P14902 1/20 0.41
▸ TDO2 P48775 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932575 0.86 CYP1A2 (0.44) CYP1A2ACVR1NPC1AURKATTK
SCHEMBL20873063 0.85 CYP1A2 (0.59) CYP1A2NPC1TGFBR1MAPK14RAB9A
SCHEMBL17932588 0.83 CYP1A2 (0.48) CYP1A2ACVR1NPC1AURKATTK
SCHEMBL17932587 0.81 CYP1A2 (0.56) CYP1A2ACVR1NPC1AURKATTK
SCHEMBL13649228 0.80 CYP1A2 (0.54) CYP1A2NPC1TGFBR1MAPK14GRM4
SCHEMBL19991864 0.79 PIK3CA (0.59) CYP1A2ACVR1NPC1AURKATTK
SCHEMBL30583075 0.79 PIK3CA (0.59) CYP1A2ACVR1NPC1AURKATTK
SCHEMBL18858305 0.78 ESR1 (0.55) NPC1RAB9AIDO1TDO2
SCHEMBL17449888 0.78 NPC1 (0.44) NPC1RAB9AIDO1TDO2CA12
SCHEMBL18594102 0.77 ACVR1 (0.55) CYP1A2ACVR1NPC1AURKATTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230403927-A1 AROMATIC COMPOUNDS UDC IRELAND LTD (IE) 2023-12-14 — — US disclosed
US-20230403927-A1 AROMATIC COMPOUNDS UDC IRELAND LTD (IE) 2023-12-14 — — US disclosed
US-11800787-B2 Metal complexes UDC IRELAND LIMITED (IE) 2023-10-24 — — US disclosed
US-11800787-B2 Metal complexes UDC IRELAND LIMITED (IE) 2023-10-24 — — US disclosed
EP-3160976-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-24 — — EP disclosed
US-20170141329-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-05-18 — — US disclosed
US-20170141329-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230403927-A1 AROMATIC COMPOUNDS TYR, CTCF, MITF CYP1A2 951/4885ACVR1 2204/4885NPC1 3191/4885
US-20170141329-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 CYP1A2 4021/4885ACVR1 4866/4885NPC1 3855/4885
US-11800787-B2 Metal complexes AP1M1, SOD1, AP3M1 CYP1A2 4021/4885ACVR1 4866/4885NPC1 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback